Latest Episodes
Short stature: Key challenges in diagnosis and management. Part 1
Do you know how to differentiate between growth hormone deficiency (or GHD) and primary IGF-I deficiency (or growth hormone resistance) and the key challenges...
Gene therapy and gene-modified cell therapy in rare diseases
Gene therapy and gene-modified cell therapies have a great potential for rare diseases to either help patients to cure their disease or improve their...
Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2
Robert Mitchell-Thain, CEO of the PBC Foundation, Edinburgh, UK and Kath Houghton, Autoimmune Specialist Nurse, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK,...
Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 1
Prof. Gideon Hirschfield, Professor of Medicine, Division of Gastroenterology, University of Toronto, Canada and Dr Emma Culver, Consultant Hepatologist and Honorary Senior Lecturer at...
Neuroendocrine tumours: The role of SSA at progression - To continue or not?
In this podcast, Prof. Martyn Caplin and Dr Aman Chauhan discuss the role of somatostatin analogues (SSAs) at progression and whether to continue or...
Rare bone disease: Highlights from ASBMR 2022 - Part 3
In this third episode of a three-episode podcast series, COR2ED and ASBMR have partnered with patient advocates Inês Alves (European Rare Bone Forum) and...